EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

NETosis-Related Biomarkers in Systemic Lupus Erythematosus, Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis: A Comparative Study

Mark M Melamud iD, Anna S Tolmacheva iD, Alexey E Sizikov iD, Nataliya A Klyaus iD, Evgenii S Zhuravlev iD, Grigory A Stepanov iD, Georgy A Nevinsky iD, Valentina N Buneva iD, Evgeny A Ermakov iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262412127 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mark M Melamud und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia. Hauptthemen laut MEDLINE: Spondylitis, Ankylosing, Biomarkers, Lupus Erythematosus, Systemic, Arthritis, Rheumatoid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NETosis is assumed to be involved in the pathogenesis of common rheumatic diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS). However, the levels of circulating NETosis biomarkers and the extent of changes in these markers in specific rheumatic diseases are not fully understood. In this study, cell-free DNA (cfDNA) concentration as a non-specific marker, as well as myeloperoxidase (MPO) and citrullinated histone H3 (H3cit) as specific markers of NETosis, were investigated in SLE, RA, PsA, and AS. Analysis of covariance, accounting for sex, age and disease duration, showed that total cfDNA was elevated in SLE and AS compared with healthy subjects. Nuclear and mitochondrial cfDNA were elevated in four diseases. However, nuclear cfDNA was increased to a greater extent in SLE but mitochondrial cfDNA was higher in RA. MPO and H3cit were significantly elevated in SLE compared with other diseases, although MPO was also higher in RA. Elevated concentrations of MPO and H3cit in SLE were associated with the presence of concomitant cardiovascular diseases. The effect of biological therapy on mitochondrial cfDNA, MPO, and H3cit was also shown. The proinflammatory cytokine IL-18, implicated in the induction of NETosis, was similarly elevated in the four rheumatic diseases. Thus, the most striking signs of NETosis are found in SLE, although they are also present in RA. PsA and AS were mainly characterized by an increase in cfDNA. These data highlight characteristic changes in NETosis markers in four rheumatic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spondylitis, AnkylosingBiomarkersLupus Erythematosus, SystemicArthritis, RheumatoidArthritis, PsoriaticExtracellular TrapsHumansMaleFemaleMiddle AgedAdultPeroxidaseHistonesCell-Free Nucleic Acids

Stichwörter der Autor:innen

IL-18NETosisankylosing spondylitisbiomarkerscell-free DNAcitrullinated histone H3myeloperoxidasepsoriatic arthritisrheumatoid arthritissystemic lupus erythematosus

Substanzen

BiomarkersPeroxidaseHistonesCell-Free Nucleic Acids

Autor:innen und Institutionen

  • Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
  • Department of Rheumatology, Immunopathology Clinic, Research Institute of Fundamental and Clinical Immunology, Siberian Branch of the Russian Academy of Sciences, 630099 Novosibirsk, Russia.
  • Department of Faculty Therapy with the Clinic, Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.
  • Department of Natural Sciences, Novosibirsk State University, 630090 Novosibirsk, Russia.

ORCID-Profile: Mark M Melamud, Anna S Tolmacheva, Alexey E Sizikov, Nataliya A Klyaus, Evgenii S Zhuravlev, Grigory A Stepanov, Georgy A Nevinsky, Valentina N Buneva, Evgeny A Ermakov

Förderung

  • Russian Science Foundation

Zitieren

APA

Melamud, M. M., Tolmacheva, A. S., Sizikov, A. E., Klyaus, N. A., Zhuravlev, E. S., Stepanov, G. A., Nevinsky, G. A., Buneva, V. N., & Ermakov, E. A. (2025). NETosis-Related Biomarkers in Systemic Lupus Erythematosus, Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis: A Comparative Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262412127

Vancouver

Melamud MM, Tolmacheva AS, Sizikov AE, Klyaus NA, Zhuravlev ES, Stepanov GA, et al. NETosis-Related Biomarkers in Systemic Lupus Erythematosus, Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis: A Comparative Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262412127

BibTeX
@article{Melamud2025,
  author = {Melamud, Mark M and Tolmacheva, Anna S and Sizikov, Alexey E and Klyaus, Nataliya A and Zhuravlev, Evgenii S and Stepanov, Grigory A and Nevinsky, Georgy A and Buneva, Valentina N and Ermakov, Evgeny A},
  title = {NETosis-Related Biomarkers in Systemic Lupus Erythematosus, Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis: A Comparative Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262412127}
}
Kostenlos starten →